United States — Food and Drug Administration & Brian Schall
5 shared events · Importance 4 · Last updated Jul 02, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's delayed clearance for Caris Life Sciences' TriNav Advance product is a key factor contributing to the company's financial issues and the subsequent investor investigations.
Brian Schall: Brian Schall is the contact person at the The Schall Law Firm for investors interested in participating in the investigation against Caris Life Sciences.
Jun 02, 2026 · 31 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Oculis will not pursue a filing with for its drug candidate OCS-01, following the failed clinical trials.
Brian Schall: Brian Schall is the contact person at The Schall Law Firm for investors interested in discussing their rights regarding the investigation into Oculis.
May 29, 2026 · 43 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Brian Schall interact across events, view sentiment trends, and discover connected entities.
Open Dashboard